quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:22:03·24d
ANALYSTRating
Vor Biopharma Inc. logo

Jefferies initiated coverage on Vor Biopharma with a new price target

VOR· Vor Biopharma Inc.
Health Care
Original source

Companies

  • VOR
    Vor Biopharma Inc.
    Health Care

Recent analyst ratings

  • Mar 30UpdateJefferies$50.00
  • Mar 19UpdateWells Fargo$30.00
  • Jan 9UpdateCitigroup$50.00
  • Dec 17UpdateTD Cowen-
  • Dec 9UpdateAnalyst$43.00
  • Nov 25UpdateWedbush$9.00

Related

  • SEC2d
    Amendment: SEC Form SCHEDULE 13D/A filed by Vor Biopharma Inc.
  • INSIDER2d
    SEC Form 4 filed by Ra Capital Management, L.P.
  • SEC8d
    Amendment: SEC Form SCHEDULE 13D/A filed by Vor Biopharma Inc.
  • INSIDER8d
    SEC Form 4 filed by Ra Capital Management, L.P.
  • SEC13d
    Amendment: SEC Form SCHEDULE 13D/A filed by Vor Biopharma Inc.
  • INSIDER13d
    SEC Form 4 filed by Ra Capital Management, L.P.
  • INSIDER14d
    SEC Form 3 filed by new insider Sokolove Jeremy Brett
  • SEC15d
    Amendment: SEC Form SCHEDULE 13D/A filed by Vor Biopharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022